...
机译:在多药结核结核中取代二线可注射剂时,改善了贝壳奎石的治疗结果:回顾性队列研究
Univ Cape Town Dept Med Cape Town South Africa;
Univ Cape Town Dept Med Cape Town South Africa;
Univ Cape Town Dept Med Cape Town South Africa;
Univ Cape Town Fac Hlth Sci Clin Res Ctr Cape Town South Africa;
Univ Cape Town Prov Hlth Data Ctr Western Cape Dept Hlth Cape Town South Africa;
Univ Cape Town Dept Med Cape Town South Africa;
Univ Cape Town Dept Med Cape Town South Africa;
Univ Cape Town Prov Hlth Data Ctr Western Cape Dept Hlth Cape Town South Africa;
Prov Govt Western Cape Dept Hlth Cape Town South Africa;
Prov Govt Western Cape Dept Hlth Cape Town South Africa;
Univ Cape Town Dept Med Cape Town South Africa;
Univ Cape Town Dept Med Cape Town South Africa;
bedaquiline; drug-resistant tuberculosis; HIV-associated tuberculosis;
机译:在多药结核结核中取代二线可注射剂时,改善了贝壳奎石的治疗结果:回顾性队列研究
机译:埃塞俄比亚阿哈拉地区二线抗结核治疗耐药结核病患者的贫困治疗结果及其预测因子的时间:回顾性队列研究
机译:多药耐药和广泛耐药结核病患者对二线注射剂的耐药性和治疗结果
机译:多药抗性结核病患者Mellozan免疫调节器的复杂处理
机译:耐多药结核病(MDR-TB)治疗结果的相关性:系统评价和荟萃分析。
机译:代替贝达喹啉的多药耐药性肺结核替代二线可注射药物的治疗结果:回顾性队列研究
机译:在耐多药和广泛耐药结核病例中对二线注射剂和治疗结果的耐药性。